Register Now | International 2022 Drug-induced Kidney Injury Biomarker Workshop
On May 23-24 the International Drug-induced Kidney Injury Biomarker Workshop will be held in a virtual format. Critical Path Institute, in collaboration with key opinion leaders from academic institutions, the pharmaceutical industry, health authorities and the patient community, is hosting this two-day public workshop for stakeholders to come together and align on a plan for developing improved tools to predict and detect drug-induced kidney injury (DIKI). We encourage you to attend both days.
DIKI Biomarker Workshop: Day 1 May 23, 2022: 10:00 AM – 3:00 PM EST |
||
Session 1: Defining the Challenge and Unmet Need | ||
Time | Topic | Summary |
10:00 – 10:05 AM | Welcome | |
10:05 – 10:30 AM | Stakeholder Perspectives | Perspectives on drug safety and data sharing |
10:30 – 10:50 AM | Understanding Drug-Induced Kidney Injury (DIKI) | Need for improved tools to inform decision making, including workshop’s focus on DIKI biomarkers |
10:50 – 11:20 AM | Defining the Challenge of DIKI | Defining the scope of the problem including the need for education, current inadequate tools/biomarkers, and need for data sharing |
11:20 – 11:35 AM | Current Landscape | Understanding current activities and opportunities and addressing ways to collaborate to make the highest impact |
11:35 – 12:35 PM | Leveraging DIKI Biomarkers to Inform Decision Making for Phase I – III Clinical Trials | Insights into biomarker strategy and outcomes, barriers, and challenges, preparing novel biomarkers for application in clinical trial decision making; how access to additional biomarker data would have improved study design and decision making before and after trials |
12:35 – 12:45 PM | Break | |
12:45 – 1:30 PM | Panel Discussion | |
Session 2: Addressing the Unmet Need Through Collaborations | ||
1:30 – 1:40 PM | Personal Perspectives | Perspectives from individuals living with kidney disease |
1:40 – 2:10 PM | Addressing the Unmet Needs | Outline and discuss an action plan framework for implementing broad DIKI biomarker use |
2:10 – 2:55 PM | Breakout Sessions/Q&A | Three breakout options to discuss what needs to be done to advance novel kidney injury biomarker development:
|
2:55 | Closing Comments | |
3:00 PM | END OF DAY 1 |
DIKI Biomarker Workshop: Day 2 May 24, 2022: 9:00 AM – 2:00 PM EST |
||
Session 3: Building Solutions and Innovative Drug Development Tools |
||
Time | Topic | Summary |
9:00 – 9:10 AM | Welcome | |
9:10 – 9:20 AM | Personal Perspective | Perspectives from individuals living with kidney disease |
9:20 – 9:30 AM | Breakout Session Highlights | Overview of day one breakout session outcomes |
9:30 – 10:35 AM | Success through Collaboration |
|
10:35 – 11:05 AM | Panel Discussion | |
11:05 – 11:35 AM | Breakout Sessions | Three breakout options to discuss implementation of an action plan to advance novel kidney injury biomarker development:
|
11:35 – 11:45 AM | BREAK | |
11:45 – 12:15 PM | Overcoming Barriers to Data Sharing: Why and How | |
12:15 – 12:40 PM | Data Sharing for Solutions |
|
12:40 – 1:30 PM | Panel Discussion | |
1:30 – 1:50 PM | Next Steps | A collaboration to advance the action plan |
1:50 PM | END OF WORKSHOP |